Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Machine learning based CRISPR gRNA design for therapeutic exon skipping

Machine learning based CRISPR gRNA design for therapeutic exon skipping

Thumbnail Image
Download
Name

journal.pcbi.1008605.pdf

Description
Published version
Size

2.53 MB

Format

Adobe PDF

Checksum (MD5)

d8ea4d8649c296fdcbdac3464a812788

sword-2022-06-28T13:35:03.original.xml (130 B)
Original SWORD entry document
Author(s)
Louie, Wilson
•
Shen, Max W
•
Tahiry, Zakir
•
Zhang, Sophia
•
Worstell, Daniel
•
Cassa, Christopher A
•
Sherwood, Richard I
•
Gifford, David K
Date Issued
2021
Journal
PLoS Computational Biology
Publisher
Public Library of Science (PLoS)
Citation
Louie, Wilson, Shen, Max W, Tahiry, Zakir, Zhang, Sophia, Worstell, Daniel et al. 2021. "Machine learning based CRISPR gRNA design for therapeutic exon skipping." PLoS Computational Biology, 17 (1).
Version
Final published version
Abstract
© 2021 Louie et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Restoring gene function by the induced skipping of deleterious exons has been shown to be effective for treating genetic disorders. However, many of the clinically successful therapies for exon skipping are transient oligonucleotide-based treatments that require frequent dosing. CRISPR-Cas9 based genome editing that causes exon skipping is a promising therapeutic modality that may offer permanent alleviation of genetic disease. We show that machine learning can select Cas9 guide RNAs that disrupt splice acceptors and cause the skipping of targeted exons. We experimentally measured the exon skipping frequencies of a diverse genome-integrated library of 791 splice sequences targeted by 1,063 guide RNAs in mouse embryonic stem cells. We found that our method, SkipGuide, is able to identify effective guide RNAs with a precision of 0.68 (50% threshold predicted exon skipping frequency) and 0.93 (70% threshold predicted exon skipping frequency). We anticipate that SkipGuide will be useful for selecting guide RNA candidates for evaluation of CRISPR-Cas9-mediated exon skipping therapy.
MIT Department
Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Massachusetts Institute of Technology. Computational and Systems Biology Program
Massachusetts Institute of Technology. Department of Biological Engineering
Terms of Use
Creative Commons Attribution 4.0 International license
https://creativecommons.org/licenses/by/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/143572
DOI of Published Version
https://doi.org/10.1371/JOURNAL.PCBI.1008605
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.